钌配合物诱导肿瘤细胞凋亡的信号通路及其作用机制

钌配合物作为抗癌药物的研究已经受到了国际研究者的广泛关注.近年来,新型结构钌配合物的设计合成;钌配合物在细胞凋亡、信号传递、基因、蛋白表达等过程中的调控作用成为新的研究热点,金属钌配合物抗癌活性机制得到进一步的阐释.本文主要对钌配合物诱导肿瘤细胞凋亡及其信号通路以及蛋白调控等抗肿瘤机制的研究进行评述.主要包括:已经进入...     

金属钌配合物的抗肿瘤活性及其作用机理

金属配合物在医药领域起着重要的作用,金属钌配合物在抗肿瘤活性研究方面取得了重要的进展.结合本组的研究工作,本文对金属钌配合物在抗肿瘤活性以及抗肿瘤作用机制方面的研究进展进行了综述.     

钌配合物断裂DNA及其机理研究

DNA是遗传信息的携带者和基因表达的物质基础,金属配合物与DNA的相互作用研究受到广泛关注,成为生物无机化学的重要研究内容之一.与其他类型金属配合物相比,钌配合物具有良好的热力学稳定性以及丰富的光化学、光物理和氧化还原特性,其作为DNA断裂试剂也引起人们的极大兴趣.以近年一些代表性的研究工作为例,本文对钌配合物在DNA断裂作用机制方面的研究进展进行了综述.     

手性钌配合物的合成、抗肿瘤活性及其与血清蛋白的相互作用

合成了手性钌配合物Δ, Λ-[Ru(bpy)₂(pyip)]²⁺, 通过元素分析、核磁共振、质谱和CD光谱对配合物进行了表征. 采用MTT法评价了3种异构体对多种肿瘤细胞株的体外抗肿瘤活性以及对正常细胞的毒性. 结果表明, Δ-[Ru(bpy)₂(pyip)]²⁺的抗肿瘤活性明显优于其异构体, 对A375, SW480, MCF-7和A549的半数抑制浓度低于顺铂. 通过荧光光谱法研究了在生理pH条件下, 手性钌配合物与牛血清白蛋白(BSA)之间的结合作用以及荧光猝灭机制. 依据Scatchard方程测定了结合常数和结合位点数, 根据热力学方程讨论了两者间的主要作用力类型. 结果表明, 钌配合物对牛血清白蛋白的荧光猝灭机制为静态猝灭. Δ-1, 1和Λ-1与牛血清白蛋白的结合常数分别为1.16×10⁵, 5.12×10⁴和3.64×10⁴, 结合位点数均为1, 主要作用力类型是静电作用. 钌配合物在体内能够被血清蛋白存储转运且结合时对蛋白构象无影响.     

钌配合物抗肿瘤研究新进展*

钌配合物作为抗癌药物的研究已受到广泛关注,成为无机药物化学的重要研究内容之一。本文简要评述了近年来钌配合物的抗肿瘤活性研究进展,包括作为细胞毒药物的钌配合物设计与筛选、钌配合物以端粒酶、DNA拓扑异构酶及蛋白激酶作为抗肿瘤作用新靶点等。     

小分子钌配合物的药学研究

小分子钌配合物是一类新颖的抗肿瘤试剂,也是一类很好的活性光敏剂,可用作生物探针探测核酸的化学结构与功能部位、用于生物活性羰基体系的成像以及用于阿尔茨海默症使Aβ聚集体的成像等。本文主要对小分子钌配合物的最近药学研究进展进行综述。     

铑配合物的抗肿瘤活性及其作用机制研究

自从Rosenberg等人发现顺铂具有抗肿瘤活性以来，金属配合物的抗肿瘤活性引起了人们的广泛关注。本文综述了近年来铑配合物抗肿瘤活性的研究进展，并对铑配合物的抗肿瘤机制和构效关系进行了探讨，为进一步寻找高效低毒和抗肿瘤谱广的新药物揭示了可循的途径。     

钌多吡啶配合物与DNA相互作用研究新进展

DNA是携带遗传信息和基因表达的基本物质.因为复杂的生物环境以及外源因素的影响,DNA存在灵活多变的结构,而不同的构型都有其独特的意义和重要的生物学功能,相关研究受到越来越广泛的关注.本文主要针对近年来钌多吡啶化合物与DNA相互作用研究的最新进展做一综述,包括DNA结构的识别,DNA二级、三级结构的调控,DNA光交联以及作为非病毒基因载体,细胞成像以及抗肿瘤等方面的应用.     

钌多吡啶配合物的合成及结合DNA的研究

合成了咪唑并［ｆ］邻菲咯啉（ＩＰ）和２－苯基咪唑并［ｆ］邻菲咯啉（ＰＩＰ）两种新的配体及［Ｒｕ·（ｂｐ）２（ＩＰ）］￣（２＋）（简称ｂ２ＩＰ）、［Ｒｕ（ｂｐｙ）２（ＰＩＰ）］￣（２＋）（简称ｂ２ＰＩＰ）、［Ｒｕ（ｐｈｅｎ）２（ＩＰ）］￣（２＋）（简称ｐ２ＩＰ）和［Ｒｕ（ｐｈｅｎ）２（ＰＩＰ）］￣（２＋）（简称ｐ２ＰＩＰ）４种新混配物。用电子吸收、稳态发光、圆二色谱研究了配合物与小牛胸腺ＤＮＡ的结合情况。总的结合强度顺序为：ｂ２ＩＰ＜ｂ２ＰＩＰ≤ｐ２ＩＰ＜ｐ２ＰＩＰ，这与配体的平面大小、π电子扩展程度和疏水性顺序（ｂｐｙ＜＜ｐｈｅｎ＜ＩＰ＜ＰＩＰ）是一致的。证明了配合物与ＤＮＡ存在插入结合。ＣＤ谱表明这种结合有对映体选择性．     

靶向抑制拓扑异构酶和端粒酶的钌配合物研究进展

金属配合物抗肿瘤研究,尤其是铂类药物,已取得了相对令人瞩目的成功,但同时也面临着包括耐药性和毒副作用等诸多问题。近年来钌配合物作为新的抗癌药物引起了人们的注意。在非铂系药物中,金钌配合物;拓扑异构酶;G-四链体;端粒酶属钌配合物是最有前途的抗癌药物之一,国际上普遍认为钌和钌的配合物属于低毒性,容易吸收并在体内很快排泄。本文将着重介绍钌配合物与DNA结合后进一步引发的细胞内核酶活性抑制研究,从新的角度来诠释钌配合物的抗肿瘤研究最新进展。     

靶向抑制拓扑异构酶和端粒酶的钌配合物研究进展

金属配合物抗肿瘤研究,尤其是铂类药物,已取得了相对令人瞩目的成功,但同时也面临着包括耐药性和毒副作用等诸多问题。近年来钌配合物作为新的抗癌药物引起了人们的注意。在非铂系药物中,金属钌配合物是最有前途的抗癌药物之一,国际上普遍认为钌和钌的配合物属于低毒性,容易吸收并在体内很快排泄。本文将着重介绍钌配合物与DNA结合后进一步引发的细胞内核酶活性抑制研究,从新的角度来诠释钌配合物的抗肿瘤研究最新进展。     

多吡啶钌配合物作为DNA结构探针的研究

本文对多吡啶钌配合物作为DNA荧光或结构探针的研究背景、研究技术及其特点、钌配合物与DNA的键合模式及其结合力大小的影响因素、钌配合物与DNA键合的异构选择性及不同键合速率、非放射性核酸标记及DNA分子光开关等方面进行了简要述评     

Stabilization of G‐Quadruplex DNA,Inhibition of Telomerase Activity and Live Cell Imaging Studies of Chiral Ruthenium(II) Complexes

Telomerase inhibition is an attractive strategy for cancer chemotherapy. In the current study, we have synthesized and characterized two chiral ruthenium(II) complexes, namely, Λ‐[Ru(phen)₂(p‐MOPIP)]²⁺ and Δ‐[Ru(phen)₂(p‐MOPIP)]²⁺, where phen is 1,10‐phenanthroline and p‐MOPIP is 2‐(4‐methoxyphenyl)‐imidazo[4,5f][1,10]phenanthroline. The chiral selectivity of the compounds and their ability to discriminate quadruplex DNA were investigated by using UV/Vis, fluorescence spectroscopy, circular dichroism spectroscopy, fluorescence resonance energy transfer melting assay, polymerase chain reaction stop assay and telomerase repeat amplification protocol. The results indicate that the two chiral compounds could induce and stabilize the formation of antiparallel G‐quadruplexes of telomeric DNA in the presence or absence of metal cations. We report the remarkable ability of the two complexes Λ‐[Ru(phen)₂(p‐MOPIP)]²⁺ and Δ‐[Ru(phen)₂(p‐MOPIP)]²⁺ to stabilize selectively G‐quadruplex DNA; the former is a better G‐quadruplex binder than the latter. The anticancer activities of these complexes were evaluated by using the MTT assay. Interestingly, the antiproliferative activity of Λ‐[Ru(phen)₂(p‐MOPIP)]²⁺ was higher than that of Δ‐[Ru(phen)₂(p‐MOPIP)]²⁺, and Λ‐[Ru(phen)₂(p‐MOPIP)]²⁺ showed a significant antitumor activity in HepG2 cells. The status of the nuclei in Λ/Δ‐[Ru(phen)₂(p‐MOPIP)]²⁺‐treated HepG2 cells was investigated by using real‐time living cell microscopy to determine the effects of Λ/Δ‐[Ru(phen)₂(p‐MOPIP)]²⁺ on intracellular accumulation. The results show that Λ/Δ‐[Ru(phen)₂(p‐MOPIP)]²⁺ can be taken up by HepG2 cells and can enter into the cytoplasm as well as accumulate in the nuclei; this suggests that the nuclei were the cellular targets of Λ/Δ‐[Ru(phen)₂(p‐MOPIP)]²⁺.     

Photo-Oxidizing Ruthenium(II) Complexes with Enhanced Visible-Light Absorption and G-quadruplex DNA Binding Abilities

Photosensitizers that gather high photo-oxidizing power and strong visible-light absorption are of great interest in the development of new photo-chemotherapeutics. Indeed, such compounds constitute attractive candidates for the design of type I photosensitizers that are not dependent on the presence of oxygen. In this paper, we report on the synthesis and studies of new ruthenium(II) complexes that display strong visible-light absorption and can oxidize guanine residues under visible-light irradiation, as evidenced by nanosecond transient absorption spectroscopy. The reported compounds also tightly bind to G-quadruplex DNA structures from the human telomeric sequence (TTAGGG repeat). The kinetic and thermodynamic parameters of the interaction of these Ru(II) complexes with G-quadruplex and duplex DNA were studied thanks to luminescence titrations and bio-layer interferometry measurements, which revealed higher affinities towards the non-canonical G-quadruplex architecture. Docking experiments and non-covalent ionic analysis allowed us to gain information on the mode and the strength of the interaction of the compounds towards G-quadruplex and duplex DNA. The different studies emphasize the substantial influence of the position and the number of non-chelating nitrogen atoms on the interaction with both types of DNA secondary structures.     

Arene Ru(II) Complexes Acted as Potential KRAS G-Quadruplex DNA Stabilizer Induced DNA Damage Mediated Apoptosis to Inhibit Breast Cancer Progress

A series of arene Ru(II) complexes, [(η⁶-MeC₆H₅)Ru(L)Cl]Cl, (L=o-ClPIP, 1; m-ClPIP, 2 and p-ClPIP, 3) (o-ClPIP=2-(2-chlorophenyl)imidazo[4,5-f][1,10]phenanthroline; m-ClPIP=2-(3-chlorophenyl)imidazo[4,5-f][1,10]phenanthroline; p-ClPIP=2-(4-chlorophenyl)imidazo[4,5-f][1,10]phenanthroline) was synthesized and investigated as a potential apoptosis inducer in chemotherapy. Spectroscopy and molecular docking simulations show that 1 exhibits moderated binding affinity to KRAS G-quadruplex DNA by groove mode. Further, in vitro studies reveal that 1 displays inhibitory activity against MCF-7 growth with IC₅₀ = 3.7 ± 0.2 μM. Flow cytometric analysis, comet assay, and immunofluorescence confirm that 1 can induce the apoptosis of MCF-7 cells and G0/G1 phase arrest through DNA damage. In summary, the prepared arene Ru(II) complexes can be developed as a promising candidate for targeting G-quadruplex structure to induce the apoptosis of breast cancer cells via binding and stabilizing KRAS G-quadruplex conformation on oncogene promoter.     

钌(II)多吡啶配合物光断裂DNA的实验研究

研究了一系列钌(II)多吡啶配合物对pBR 322 DNA 的光断裂作用, 并与光谱法和粘度法的研究结果进行了对比. 实验结果表明, 钌(II)多吡啶配合物光断裂DNA的能力不仅与配合物与DNA相互作用的结合模式和结合强度有关, 还与配合物自身的电子结构有关; 钌(II)多吡啶配合物对DNA的光断裂存在立体选择性; 其断裂机理是激发态的配合物与溶液中的氧分子发生能量转移生成单线态氧活性氧化物种, 将鸟嘌呤碱基氧化而导致DNA断裂. 本研究对于遗传工程中的化学核酸酶以及以DNA为靶标的药物设计有重要的意义.     

Effect of Electronic Structures of Enantiomers of Ruthenium(II) Polypyridyl Complexes on DNA Binding Behaviors

A pair of Ru(II) complex enantiomers, Δ‐ and Λ‐[Ru(bpy)₂(p‐mpip)]²⁺ {bpy=2,2′‐bipyridine, p‐mpip=2‐(4‐methylphenyl)imidazo[4,5‐f]‐1,10‐phenanthroline} have been synthesized and structurally characterized. Both experimental results from crystallography, NMR, electrochemistry and theoretical calculations applying the density functional theory (DFT) method based on their crystal structures show that small difference in geometric structure existed can cause a considerable difference in electronic structure between enantiomers. In addition, the binding of the two enantiomers to calf thymus DNA (CT DNA) has been investigated with UV spectroscopy titration and viscosity measurements. It is very rare that the Λ enantiomer binds to DNA more strongly than the Δ enantiomer, which can be reasonably explained by their different electronic structures for the first time, suggesting that the dominant factor governing the stereoselectivity of DNA binding of Ru(II) complex may be the different electronic structures of its enantiomers.     

钌(II)多吡啶配合物与DNA相互作用研究*

DNA是遗传信息的携带者和基因表达的物质基础,金属配合物与DNA的相互作用研究已受到广泛关注,成为生物无机化学的重要研究内容之一。本文简要评述了钌(II)多吡啶配合物在DNA识别、断裂及拓扑异构酶抑制方面的研究情况。